Cell & Gene Therapy In Conversation: Q&A With Seven Experts

As cell and gene therapies move from concept to clinic, developers face mounting challenges in reproducibility, scalability, and regulatory compliance. In this expert Q&A, seven leaders in the field offer practical insights into how innovation is reshaping the development process. The discussion explores how precision-engineered tools and advanced analytics are helping teams achieve consistent, high-quality results. Experts also share strategies for streamlining scale-up to emphasize the importance of seamless transitions from R&D to commercial manufacturing. Regulatory compliance takes center stage in the final segment, with examples of how technology supports data integrity and global documentation standards.

Whether you're navigating early development or preparing for commercial launch, this conversation offers actionable guidance for accelerating progress in advanced therapies.